Development Of a Virtual Stress Inoculation Training (SIT) Platform and Mobile Health App

Description

The purpose of this study is to demonstrate the feasibility and utility of SIT delivered asynchronously (self-paced) via fully virtual platform with and without the aid of a mobile health application and to determine initial change over baseline in terms of reduction in PTSD symptoms and improvement in resiliency in participants receiving the virtual SIT prototype, using Linear Mixed Models (LMMs),

Conditions

PTSD, Trauma and Stressor Related Disorders, Traumatic Brain Injury

Study Overview

Study Details

Study overview

The purpose of this study is to demonstrate the feasibility and utility of SIT delivered asynchronously (self-paced) via fully virtual platform with and without the aid of a mobile health application and to determine initial change over baseline in terms of reduction in PTSD symptoms and improvement in resiliency in participants receiving the virtual SIT prototype, using Linear Mixed Models (LMMs),

Development Of a Virtual Stress Inoculation Training (SIT) Platform and Mobile Health App

Development Of a Virtual Stress Inoculation Training (SIT) Platform and Mobile Health App

Condition
PTSD
Intervention / Treatment

-

Contacts and Locations

Houston

The University of Texas Health Science Center at Houston, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * US Military Veterans / Service Members
  • * diagnosis of PTSD as measured by a Posttraumatic Symptom Checklist for DSM-5 (PCL-5) score of \>33
  • * history of combat trauma and/or military service in an imminent danger pay area
  • * be fluent in English.
  • * be capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form and in this protocol.
  • * have access to a SmartPhone or tablet to utilize the mobile health app and/OR access the virtual classroom.
  • * agree to undergo psychometric testing and participate in ongoing assessments throughout the study duration.
  • * be willing to comply with all study procedures, able to complete all assessments independently, and available for the duration of the study.
  • * Active suicidal ideation as assessed by the Investigator at screening or as identified during the study.
  • * Clinically significant history of psychotic disorder, bipolar spectrum disorder, or neurodegenerative disease/dementia as assessed by the Investigator.
  • * Active severe substance abuse as assessed by the investigator in accordance with DSM-5 Substance Abuse Disorder criteria, an AUDIT score \> 15, or partial Brief Addiction Monitor (BAM) indicating the presence of illicit substance use other than cannabis (\< 3 times weekly).
  • * They are currently undergoing another form of treatment other than supportive therapy (\> 2 times per month).
  • * Engaged in active trauma-focused therapy including Cognitive Processing Therapy (CPT)Prolonged Exposure (PE), or Eye Movement Desensitization and Reprocessing (EMDR).
  • * Any other condition/situation that the Investigator believes may interfere with participant safety, study conduct, or interpretation of study data.

Ages Eligible for Study

18 Years to 79 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The University of Texas Health Science Center, Houston,

Sarah Jackson, PhD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

2025-06-30